Suicide, depression, and antidepressants - Patients and clinicians need to balance benefits and harms

Suicide, depression, and antidepressants - Patients and clinicians need to balance benefits and harms

Dettagli Bibliografici
Autori principali:	Cipriani, A, Barbui, C, Geddes, JR
Natura:	Journal article
Pubblicazione:	2005

Documenti analoghi

Suicide, depression, and antidepressants.
di: Cipriani, A, et al.
Pubblicazione: (2005)

Risk of suicidal behaviour in adults taking antidepressants.
di: Geddes, JR, et al.
Pubblicazione: (2009)

Risk of suicidal behaviour in adults taking antidepressants
di: Geddes, JR, et al.
Pubblicazione: (2009)

Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data.
di: Barbui, C, et al.
Pubblicazione: (2008)

Long-term treatment of depression with antidepressants: a systematic narrative review.
di: Furukawa, T, et al.
Pubblicazione: (2007)

Ranking antidepressants Reply
di: Cipriani, A, et al.
Pubblicazione: (2009)

Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.
di: Cipriani, A, et al.
Pubblicazione: (2007)

Do selective serotonin reuptake inhibitors cause suicide? Suicide rate of 15% in editorial is misleading - Reply
di: Cipriani, A, et al.
Pubblicazione: (2005)

Depressive disorder needs an evidence base commensurate with its public health importance.
di: Geddes, J, et al.
Pubblicazione: (2007)

Mirtazapine versus other antidepressive agents for depression.
di: Watanabe, N, et al.
Pubblicazione: (2011)

Antidepressants in unipolar major depression: what we need to know
di: Barber, S, et al.
Pubblicazione: (2016)

The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?
di: Michele Fornaro, et al.
Pubblicazione: (2019-05-01)

Escitalopram versus other antidepressive agents for depression.
di: Cipriani, A, et al.
Pubblicazione: (2009)

Sertraline versus other antidepressive agents for depression.
di: Cipriani, A, et al.
Pubblicazione: (2009)

Sertraline versus other antidepressive agents for depression.
di: Cipriani, A, et al.
Pubblicazione: (2010)

Sertraline versus other antidepressive agents for depression
di: Cipriani, A, et al.
Pubblicazione: (2010)

Milnacipran versus other antidepressive agents for depression.
di: Nakagawa, A, et al.
Pubblicazione: (2009)

Venlafaxine for major depression.
di: Cipriani, A, et al.
Pubblicazione: (2007)

Are all antidepressants really the same? The case of fluoxetine: a systematic review.
di: Cipriani, A, et al.
Pubblicazione: (2006)

Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis.
di: Barbui, C, et al.
Pubblicazione: (2011)

"Wish bias" in antidepressant drug trials?
di: Barbui, C, et al.
Pubblicazione: (2004)

Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
di: Cipriani, A, et al.
Pubblicazione: (2008)

Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal?
di: Barbui, C, et al.
Pubblicazione: (2009)

Balancing benefits and harms in health care.
di: Cuervo, L, et al.
Pubblicazione: (2003)

Depression in adults: drug and physical treatments.
di: Cipriani, A, et al.
Pubblicazione: (2011)

Depression in adults: drug and physical treatments.
di: Barbui, C, et al.
Pubblicazione: (2007)

Antidepressants for bipolar disorder: A clinical overview of efficacy and safety
di: Cipriani, A, et al.
Pubblicazione: (2008)

Antidepressants are not an effective adjunct to mood stabilisers for bipolar depression.
di: Rao, C, et al.
Pubblicazione: (2007)

Communicating the harmful effects of medicines Warnings may have unintended consequences
di: Geddes, JR, et al.
Pubblicazione: (2014)

At what level of severity do we need antidepressive drugs?
di: Cipriani, A
Pubblicazione: (2019)

Sun Exposure in Children: Balancing the Benefits and Harms
di: Ankur K Jindal, et al.
Pubblicazione: (2020-01-01)

Communicating the harmful effects of medicines.
di: Geddes, J, et al.
Pubblicazione: (2014)

Antidepressants in children and adolescents: meta-review of efficacy, tolerability and suicidality in acute treatment
di: Boaden, K, et al.
Pubblicazione: (2020)

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
di: Watanabe, N, et al.
Pubblicazione: (2008)

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
di: Nakagawa, A, et al.
Pubblicazione: (2008)

Effect of antidepressants on thyroid hormone level in adolescent depression with suicidal ideation
di: ZHANG Jiali, et al.
Pubblicazione: (2023-08-01)

Maternal Depression and Antidepressant Use During Pregnancy and Associations with Depressive Symptoms and Suicidality in Adolescent Children
di: Beck-Pancer D, et al.
Pubblicazione: (2023-05-01)

Relapse prevention in antidepressant drug treatment in depressive disorders: a systematic review (vol 361, pg 653, 2003)
di: Geddes, JR, et al.
Pubblicazione: (2004)

SSRIs versus other antidepressants for depressive disorder.
di: Geddes, J, et al.
Pubblicazione: (2000)

Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment
di: Katharine Boaden, et al.
Pubblicazione: (2020-09-01)